Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics
April 17, 2023
Vito Romita and Jai Balkissoon
Cell therapy clinical trials pose a variety of complex challenges. Logistics with cell harvesting, manufacturing, shipments back to sites, patient safety, changing standard-of-care treatments, and patient enrolment due to competing trials can all impact study timelines. In this episode, Vito Romita and Jai Balkissoon outline key obstacles for developing cell therapies in oncology, and provide their insights on overcoming them in order to increase patient access and design safer trials.
To read this interview and access lots more content, visit the Cell and Gene Therapy Insights website
What do you see as the three most important challenges with the current development of cell therapies in oncology?
What can industry leaders, stakeholders and sponsors do to improve patient access for cell and gene therapy clinical trials?
How can we make complex cell and gene therapy trials more understandable to patients and their primary caregivers?
Finally, what can be done to help design safer cell therapy trials?